BILL ANALYSIS

HR7789

NEUTRAL

Federal Loan Systems Modernization Act of 2026

HR7789 (Federal Loan Systems Modernization Act of 2026) has been assessed with a neutral outlook for investors. The primary sectors impacted are Technology. View the full bill text on Congress.gov.

neutral

Market Sentiment

0

Affected Stocks

1

Sectors Impacted

Key Takeaways for Investors

1

HR 7789 authorizes but does NOT fund a Lending.gov platform — zero dollars are allocated

2

Actual contract awards require a separate appropriations bill that does not exist

3

IT services and software companies (ORCL, IBM, ACN, SAIC, LDOS) are potential future beneficiaries but see zero near-term impact

4

Bill is in earliest legislative stage — referred to committee with no hearings scheduled

5

Do not trade this stock list based on this bill; there is no revenue, no contracts, no timeline

How HR7789 Affects the Market

This bill has zero current market implications. The tickers listed represent companies that would compete for future government IT contracts if this program ever gets funded, but no such funding exists today. The market data confirms no stock movement related to this legislation — Oracle's 7-day decline of 6.52% and 30-day gain of 10.11% are driven by earnings and cloud market dynamics, not an unfunded authorization bill that passed zero actions in nearly two months. IBM, Accenture, SAIC, and Leidos are all trading on their own corporate fundamentals. Retail investors should not allocate capital based on this bill at this stage — there is no revenue, no contracts, and no defined timeline for appropriations.

Bill Details

MetricValue
Bill NumberHR7789
Market Sentimentneutral
Event Date
Affected SectorsTechnology
Affected StocksN/A
SourceView on Congress.gov →

Summary

HR 7789 (Federal Loan Systems Modernization Act) is an early-stage authorization bill with zero appropriations, no funding mechanism, and no near-term revenue impact for any company. The bill merely authorizes GSA to plan a centralized Lending.gov platform. Actual contract awards require separate appropriations legislation that does not exist. Market reaction is nonexistent.

Full AI Market Analysis

On March 4, 2026, Rep. Finstad (R-MN) introduced HR 7789, the Federal Loan Systems Modernization Act. The bill authorizes the General Services Administration (GSA) to create Lending.gov, a centralized shared-services platform for federal loan programs. The bill is in early legislative stage — referred to the House Committee on Oversight and Government Reform with no hearings scheduled. A companion bill (S3980) has been introduced in the Senate and referred to the Homeland Security and Governmental Affairs Committee. The money trail is critical: this bill is pure authorization with zero appropriations. Section by section, the bill directs GSA to plan and develop the platform, but it contains no dollar figures, no specific funding authorization ceiling, and no mechanism to transfer or allocate funds. Under standard U.S. legislative process, authorization bills set policy; actual spending requires a separate appropriations bill. Until appropriations legislation is introduced and passed, there is zero federal funding for this program. Contractors cannot bill for work that has not been funded. Structural winners and losers: This is a future-looking story for government IT contractors, not a current catalyst. Companies with strong federal IT practices — Oracle, IBM, Accenture, SAIC, and Leidos — are plausible vendors for any future Lending.gov procurement. However, with no funding and early legislative stage, there is zero current impact on their revenues, earnings, or competitive positioning. The legislation does not name any specific vendor, mandate any particular technology stack, or create any regulatory burden. Real market data shows the named IT stocks are trading on their own fundamentals, not on HR 7789. Oracle at $161.99 has fallen 6.52% in the last 7 days but is up 10.11% over 30 days — a significant earnings-related move that has nothing to do with an unfunded authorization bill. IBM at $228.93 is down 1.31% over 7 days and 5.55% over 30 days. Accenture at $177.61 is down 0.42% over 7 days and 10.43% over 30 days — these are broad market and sector trends, not bill-driven moves. SAIC and Leidos show minimal movement consistent with no catalyst. Timeline: HR 7789 has only three actions on record, all on the day of introduction (March 4, 2026). Companion bill S3980 has similarly stalled. The next required steps are: (1) committee hearings and markup, (2) House floor vote, (3) Senate passage of identical bill, (4) presidential signature, and (5) separate appropriations legislation. Step 5 is the most significant barrier — even if the authorization bill passes, the funding must be approved in a subsequent, separate bill. Realistically, this is a multi-year process with no guarantee of completion. No committee hearings have been scheduled as of the analysis date.

Sectors Impacted by HR7789

Related Technology Legislation

Understand the Terms

Free — no credit card

Know which stocks HR7789 moves — before the market does

HillSignal scores every bill, federal contract, and insider filing for market impact and emails you the high-conviction ones. Free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →